Skip to main navigation Skip to search Skip to main content

Commentary on 'Electroacupuncture Inhibited Spinal Glial Activation in Neuropathic Pain via Glucagon-like Peptide 1/Glucagon-like Peptide 1 Receptor Signaling'

Research output: Contribution to journalReview articlepeer-review

Abstract

Neuropathic pain represents a significant clinical challenge due to its complex etiology and limited treatment options. Traditional pharmacological approaches, particularly opioid therapy, are associated with significant side effects and risk of abuse, highlighting the urgent need for alternative strategies. In recent years, nonpharmacological interventions such as acupuncture and electroacupuncture have gained attention for their potential efficacy in managing neuropathic pain. Further research combining nonpharmacological interventions with targeting signaling pathways could lead to the development of innovative strategies for the management of neuropathic pain and improve the quality of life for patients suffering from this debilitating condition.

Original languageEnglish
Pages (from-to)190-191
Number of pages2
JournalJournal of Neurological Sciences
Volume41
Issue number3
DOIs
Publication statusPublished - 2024

Keywords

  • Electroacupuncture
  • glucagon-like peptide 1/glucagon-like peptide 1 receptor signaling
  • neuropathic pain

Fingerprint

Dive into the research topics of 'Commentary on 'Electroacupuncture Inhibited Spinal Glial Activation in Neuropathic Pain via Glucagon-like Peptide 1/Glucagon-like Peptide 1 Receptor Signaling''. Together they form a unique fingerprint.

Cite this